Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |